You will be given a definition of a task first, then an example. Follow the example to solve a new instance of the task.
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: "Although the story didn't cite the cost of appendectomy emergency or urgent surgery and we wish it had, we nonetheless will give it a satisfactory score because it at least cited what the editorial writer wrote, ""A secondary benefit is the savings to the hospital generated by minimizing staff and anesthesiologist presence late in the evening and during the wee hours of the morning."" As with our harms score above, although the story didn't give absolute numbers, in this case we think it was sufficient for it to report that ""The scientists found no significant difference among the groups in the patients' condition 30 days after surgery or in the length of their operation or hospital stay."" Although the story didn't give absolute numbers, in this case we think it was sufficient for it to report that ""The scientists found no significant difference among the groups in the patients' condition 30 days after surgery or in the length of their operation or hospital stay."" Despite running less than 300 words, this story did an adequate job in explaining the quality of the evidence, including pointing out limitations. No disease-mongering here. The story meets the bare minimum requirement for this criterion in that it at least cited what an editorial stated. The focus of the story was on a study comparing emergency appendectomy with surgery done up to 12 hours later or beyond. This is the whole focus of the story and one we applaud when it begins: ""Appendectomy is the most common emergency surgery in the world, but it doesn't have to be."" There were no claims made about the novelty of this research, and we may have wished for a bit more context on this. Nonetheless, the potential for guiding future care decisions was made clear. Not applicable. Given that the story only pulled excerpts from the journal article and the accompanying editorial, and didn't include any fresh quotes from interviews, we can't be sure of the extent to which it may have been influenced by a news release.". Claim: Some appendicitis cases may not require 'emergency' surgery
Solution: We really don't understand why only a handful of mainstream news organizations reported this story. (At least in what we found.) The most common emergency surgery in the world. Rushing to emergency surgery may not carry any benefit. Waiting a few hours may be safer and less expensive. Why is that not a story? We applaud USA Today for finding time and space and clearly it didn't need to free up much space to do a good job telling the story. The story explains that as many as 300,0 appendectomies are done each year in the US. That figure alone explains why this is an important study to report.
Why? The output is an analysis of the claim while considering the paragraph as a reference. The output highlights the key features presented in the paragraph and explains the claim accordingly.

New input: Paragraph: "The first shipments should start next week," said Sudarshan Jain, secretary general of Indian Pharmaceutical Alliance (IPA). India is the world's largest producer of hydroxychloroquine but last month banned most exports to secure its own supplies, drawing warnings of retaliation from Trump. This week India allowed some exports of the drug and Trump has thanked New Delhi for the decision. Jain said companies in India are ramping up capacity to meet the U.S. demand, including Teva Pharmaceutical Industries, IPCA Laboratories and Cadila Healthcare. Cadila has increased production tenfold to 30 metric tonnes per month and is ready to produce more if needed, Managing Director Sharvil Patel told Reuters. Companies are ramping up while battling a three-week nationwide lockdown India imposed on March 25. Cadila is based in western India's Gujarat state, a drug production hub where industry insiders say the shutdown has forced companies to contend with supply chain disruptions and worker shortages. "There are 28 manufacturers of hydroxychloroquine in Gujarat," said H.G. Koshia, a senior drugs department official. "All of them have enhanced production in view of rise in demand." The IPA's Jain said firms were confident they could produce adequate quantities to meet both global and domestic demand. "The government is getting a lot of requests from other countries," Jain noted. India is stocking at least four months' supply and has agreed to export to at least 30 countries, according to export body Pharmexcil's estimates. Hydroxychloroquine is unproven as a treatment here but its use has soared as the United States has quickly become the epicentre of the pandemic. U.S. deaths due to coronavirus topped 16,400, while India's death toll stands at 199. here Claim: India set to ship drug sought by Trump for coronavirus.
Solution:
India is set to begin shipping the malaria drug hydroxychloroquine to the United States where President Donald Trump has touted it as a potential weapon against the coronavirus.